Of note, none of our 34 cases with KMT2A fusion demonstrated KMT2A-AFF1 (previously MLL-AF4), or KMT2A-MLLT3 (previously MLL-AF9) fusions, commonly observed in BCP-ALL and AML respectively. This evidence concerns the gene MLLT3 and acute lymphoblastic leukemia.